Bridgewater Associates’s Hims & Hers Health HIMS Stock Holding History

Bridgewater Associates’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$244K	Sell	7,036 -34,526	-83%	-$927K	﹤0.01%	980
2026 Q1	$863K	Buy	41,562 +35,100	+543%	+$829K	﹤0.01%	812
2025 Q4	$210K	Sell	6,462 -119,319	-95%	-$5.11M	﹤0.01%	1036
2025 Q3	$7.13M	Sell	125,781 -472,248	-79%	-$24.2M	0.03%	406
2025 Q2	$29.8M	Sell	598,029 -148,896	-20%	-$6.73M	0.12%	133
2025 Q1	$22.1M	Buy	746,925 +735,345	+6,350%	+$27.3M	0.1%	166
2024 Q4	$280K	Sell	11,580 -289,492	-96%	-$7.17M	﹤0.01%	637
2024 Q3	$5.55M	Buy	301,072 +117,251	+64%	+$2.1M	0.03%	360
2024 Q2	$3.71M	Buy	183,821 +81,128	+79%	+$1.35M	0.02%	415
2024 Q1	$1.59M	Buy	+102,693	New	+$1.16M	0.01%	525

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bridgewater Associates's HIMS Position: Q2 2026 in Review

Bridgewater Associates reduced its Hims & Hers Health (HIMS) stake by 83% in Q2 2026, selling an estimated $927K and leaving 7,036 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #980.

Bridgewater Associates first reported a position in HIMS in Q1 2024 and has held it in 10 quarters since. The position peaked at $29.8M in Q2 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Bridgewater Associates held 7,036 shares of Hims & Hers Health worth $244K as of Q2 2026.
Bridgewater Associates sold 34,526 Hims & Hers Health shares in Q2 2026, an estimated $927K.
Hims & Hers Health made up ﹤0.01% of Bridgewater Associates's portfolio in Q2 2026, its #980 holding.
Bridgewater Associates first reported a position in Hims & Hers Health in Q1 2024 and has held it in 10 quarters since.
Bridgewater Associates's Hims & Hers Health position peaked at $29.8M in Q2 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.